Chaim Gilon Selected Research

G-Protein-Coupled Receptors (Receptors, G Protein Coupled)

1/2022

PH-Binding Motif in PAR4 Oncogene: From Molecular Mechanism to Drug Design.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Chaim Gilon Research Topics

Disease

6	Neoplasms (Cancer) 01/2022 - 10/2004
4	Multiple Sclerosis 12/2021 - 07/2013
2	Arthritis (Polyarthritis) 05/2015 - 09/2013
2	Rheumatoid Arthritis 09/2013 - 01/2012
1	Colonic Neoplasms (Colon Cancer) 01/2022
1	Autoimmune Diseases (Autoimmune Disease) 12/2021
1	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 12/2021
1	Cardiotoxicity 12/2020
1	Ischemia 12/2020
1	Ischemic Stroke 12/2020
1	Myocardial Infarction 12/2020
1	Stroke (Strokes) 12/2020
1	Inflammation (Inflammations) 01/2019
1	Experimental Arthritis 05/2015
1	Memory Disorders (Memory Loss) 08/2012
1	Alzheimer Disease (Alzheimer's Disease) 08/2012
1	Autistic Disorder (Autism) 08/2012
1	Hepatolenticular Degeneration (Wilson's Disease) 08/2012
1	Thalassemia 08/2012
1	Obesity 02/2008
1	Weight Gain 01/2008
1	Avian Sarcoma 09/2002
1	Infections 04/2002

Drug/Important Bio-Agent (IBA)

3	Cyclic PeptidesIBA 12/2021 - 01/2005
3	EpitopesIBA 05/2015 - 01/2012
2	Peptides (Polypeptides)IBA 12/2020 - 01/2018
2	AcidsIBA 12/2020 - 05/2015
2	Proteins (Proteins, Gene)FDA Link 01/2019 - 09/2002
2	LigandsIBA 05/2015 - 09/2013
2	MetalsIBA 08/2012 - 10/2004
2	Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA 07/2011 - 04/2010
2	Peptide Hydrolases (Proteases)FDA Link 09/2002 - 04/2002
1	platelet protein P47 (pleckstrin)IBA 01/2022
1	Proteinase-Activated ReceptorsIBA 01/2022
1	matrigelIBA 01/2022
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2022
1	IntegrinsIBA 12/2021
1	Natalizumab (Tysabri)FDA Link 12/2021
1	Therapeutic UsesIBA 12/2021
1	Monoclonal AntibodiesIBA 12/2021
1	Oxygen (Dioxygen)IBA 12/2020
1	humaninIBA 12/2020
1	Doxorubicin (Adriamycin)FDA LinkGeneric 12/2020
1	Glucose (Dextrose)FDA LinkGeneric 12/2020
1	AntigensIBA 01/2019
1	CytokinesIBA 01/2019
1	CalreticulinIBA 05/2015
1	CC ChemokinesIBA 07/2013
1	MetallothioneinIBA 08/2012
1	HLA Antigens (Human Leukocyte Antigens)IBA 01/2012
1	PeptidomimeticsIBA 02/2008
1	Type 4 Melanocortin Receptor (Melanocortin-4 Receptor)IBA 02/2008
1	RheniumIBA 01/2005
1	Gonadotropin-Releasing Hormone (GnRH)FDA Link 10/2004
1	LHRH Receptors (Gonadotropin-Releasing Hormone Receptor)IBA 10/2004
1	vif Gene ProductsIBA 09/2002

Therapy/Procedure

3	Therapeutics 01/2022 - 12/2020
2	Oral Administration 01/2019 - 01/2008
1	Immunotherapy 12/2021